[Summary] To become a trusted partner of cancer patients and doctors
Zhenhe Technology is centered on next-generation sequencing technology and bioinformatics, and is engaged in non-invasive individualized precision diagnosis and treatment of tumors and companion diagnostics. The talent team covers clinical medicine, bioinformatics, and molecular biology, with many years of deep experience in the precision medicine and high-throughput sequencing industries. The company integrates R&D, production, and medical testing, and is committed to providing safe, precise, and comprehensive individualized health guidance through technological innovation and collaborative sharing.
Zhenhe Technology's R&D center is located in Beijing Health Zhigu, with Beijing as its headquarters and six offices established nationwide. In early 2017, it completed a Series B financing of RMB 128 million. It has a 1,200 m2 open laboratory, an independent laboratory in Nanjing, and a clinical medical laboratory qualification. The company integrates R&D, production, and medical testing, and has independently developed multiple national and international invention patents and software copyrights.
Vision: We are committed to becoming the * in improving the quality of life of cancer patients.
Mission: We provide * professional precision diagnosis and treatment decisions, and become the partner * trusted by cancer patients and doctors.
Values:
Core — Customer First
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows